Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Response of Reducing Dose of Peginterferon Alfa-2a in Koreans With Chronic Hepatitis C Genotype 1; Randomized Controlled Multicenter Study 100% Versus 80%

NCT01378104 is registered in ClinicalTrials.gov with The Catholic University of Korea as lead sponsor.

NCT NCT01378104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01378104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Response of Reducing Dose of Peginterferon Alfa-2a in Koreans With Chronic Hepatitis C Genotype 1; Randomized Controlled Multicenter Study 100% Versus 80%
Lead sponsor
The Catholic University of Korea
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2008
Completion date
September 30, 2012
Enrollment
178 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

il28b polymorphism, sustained virologic response